These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Clinical study of xylite as a cholagogue]. Vaĭnshteĭn SG; Maksudova DKh; Pivikova MI Klin Med (Mosk); 1970 Jan; 48(1):126-8. PubMed ID: 5419551 [No Abstract] [Full Text] [Related]
9. [Study of an hepatic analeptic by enzyme determinations and hepatic clearance tests]. Boisson J Ann Gastroenterol Hepatol (Paris); 1972; 8(2):191-6. PubMed ID: 5056542 [No Abstract] [Full Text] [Related]
10. [The effect of cholerelics on bile flow in diseases of the liver and of the bile ducts (author's transl)]. Bode JC; Strohmeyer G Leber Magen Darm; 1974 Apr; 4(2):65-71. PubMed ID: 4828906 [No Abstract] [Full Text] [Related]
11. [Clinical experience with the amphocholeretic drug Odibil in primary and secondary organic as well as functional cholecysto- and cholangiohepathopathies]. Hunold W Z Allgemeinmed; 1975 Feb; 51(5):237-41. PubMed ID: 1093341 [No Abstract] [Full Text] [Related]
12. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system]. Nogaller AM; Barkhanova AG; Zakharova GIu Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457 [No Abstract] [Full Text] [Related]
13. [Quantitative and qualitative changes in the level of bile acids in the bile of patients with chronic hepatocholecystitis under the effect of therapy]. Karbach IaI; Zvershkhanovskiĭ FA Ter Arkh; 1970 Dec; 42(12):62-4. PubMed ID: 5511307 [No Abstract] [Full Text] [Related]
14. [New therapeutic technic in diseases of the efferent bile ducts]. Dierel H Wien Med Wochenschr; 1972 Apr; 122(14):187-90. PubMed ID: 5014036 [No Abstract] [Full Text] [Related]
15. [CLINICO-EXPERIMENTAL STUDY OF A NEW CHOLERETIC ASSOCIATED WITH AN ANTI-SPASTIC DRUG AND WITH VITAMIN B1 AND VITAMIN PP]. BENVESTITO V; MARTELLOTTA G; VIGGIANO N Clin Ter; 1963 Aug; 26():331-40. PubMed ID: 14055217 [No Abstract] [Full Text] [Related]
16. [Studies on the potency of action of several choleretics]. Mörsdorf K; Wolf G Dtsch Med J; 1966 May; 17(10):303-6. PubMed ID: 5985421 [No Abstract] [Full Text] [Related]
17. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis]. Il'chenko AA; Drozhzhina IuV Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic use of xylith in chronic cholecystitis]. Kulikova ZS Vrach Delo; 1968 Aug; 8():23-5. PubMed ID: 5741738 [No Abstract] [Full Text] [Related]
19. [Therapeutic effect of choleretic drug urocholesan in patients with chronic cholecystitis]. Nemialkovskiĭ IB Vrach Delo; 1976 Dec; (12):76-8. PubMed ID: 1014594 [No Abstract] [Full Text] [Related]